Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk Factors for Concussion in Under 18, Under 22 and Professional Men's Rugby Union: A Video Analysis of 14,809 Tackles.

Sports medicine - open·2023
Same author

Association between number of medications and hip fractures in Japanese elderly using conditional logistic LASSO regression.

Scientific reports·2023
Same author

Case fatality rate considering the lag time from the onset of COVID-19 infection to related death from 2020 to 2022 in Japan.

IJID regions·2023
Same author

Novel indicator for the spread of new coronavirus disease 2019 and its association with human mobility in Japan.

Scientific reports·2023
Same author

The impact of declaring the state of emergency on human mobility during COVID-19 pandemic in Japan.

Clinical epidemiology and global health·2022
Same author

Changes in social environment due to the state of emergency and Go To campaign during the COVID-19 pandemic in Japan: An ecological study.

PloS one·2022

Related Experiment Video

Updated: May 10, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Sharp bounds on causal effects using a surrogate endpoint.

Manabu Kuroki1

  • 1The Institute of Statistical Mathematics, 10-3, Midori-cho, Tachikawa, Tokyo, 190-8562, Japan. mkuroki@ism.ac.jp

Statistics in Medicine
|June 12, 2013
PubMed
Summary

This study provides methods to evaluate treatment effects on true outcomes using surrogate endpoints, even with unmeasured confounders. It offers sharp bounds for causal inference, aiding clinical research.

Keywords:
linear programming (LP) methodpotential outcome approachsurrogate paradox

More Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Experiment Videos

Last Updated: May 10, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Biostatistics
  • Epidemiology
  • Causal Inference

Background:

  • Evaluating treatment efficacy often relies on surrogate endpoints when true outcomes are difficult to measure.
  • Unmeasured confounders between surrogate and true endpoints complicate causal effect estimation.
  • Existing methods struggle with identifiability issues in the presence of unmeasured confounding.

Purpose of the Study:

  • To derive methods for estimating the causal effect of a treatment (X) on a true endpoint (Y) using a surrogate endpoint (S).
  • To address the challenge of unmeasured confounders affecting the relationship between S and Y.
  • To provide practical tools for researchers and clinicians to assess treatment effects.

Main Methods:

  • Derivation of closed-form formulas for sharp bounds on the causal effect of X on Y.
  • Utilizing the causal effect of X on S and the joint probability of S and Y.
  • Investigating conditions where observing Y is not necessary for testing null causal effects under monotonicity.

Main Results:

  • Sharp bounds for the causal effect of X on Y were derived under various assumptions.
  • Demonstrated that observing the true endpoint Y may not always be required for hypothesis testing.
  • The derived bounds offer a computationally efficient approach for causal effect assessment.

Conclusions:

  • The proposed bounds facilitate the evaluation of treatment effects on true endpoints using surrogate endpoints, even with unmeasured confounding.
  • These methods enhance causal inference in clinical research by providing practical estimation tools.
  • The findings reduce the reliance on observing true endpoints in certain causal effect testing scenarios.